H. Parker

H.
Stewart Parker was the founder of AmpliPhi Biosciences Corp., founded in 1992, where the title held was Chief Executive Officer & Director from 1992 to 2008.
Current jobs include Chairman at Sangamo Therapeutics, Inc. since 2017 (job started in 2014), Independent Director at Codexis, Inc. since 2022, Director at Global Partnerships, and Principal at Parker Bioconsulting since 2009.
Former jobs include President, Chief Executive Officer & Director at Immunex Corp.
from 1992 to 2008, Chief Executive Officer & Director at Infectious Disease Research Institute from 2011 to 2014, Chairman at C3 Jian LLC, President & Director at Receptech Corp.
from 1991 to 1993, Director at Neose Technologies, Inc. from 2005 to 2009, Director at Biotechnology Innovation Organization, Independent Director at IPI Legacy Liquidation Co. from 2014 to 2023, Director at Nexgenia, Inc., Director at Inventprise, Inc. from 2022 to 2025, Director at OncoGenex Technologies, Inc., Director at Regence BlueShield, Independent Director at OncoGenex Pharmaceuticals, Inc., Independent Director at Achieve Life Sciences, Inc. from 2017 to 2021, Independent Director at Armata Pharmaceuticals, Inc. from 2019 to 2020, and Director at StrideBio, Inc. from 2018 to 2023.
Education includes undergraduate degree (1979) and MBA (1981) from the University of Washington.